Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
IMNM Immunome Inc
SNMP Evolve Transition Infrastructure LP
BIOC Biocept Inc
BOXD Boxed Inc
EHTH eHealth Inc
SNCE Science 37 Holdings Inc
ONL Orion Office Reit Inc
BKKT Bakkt Holdings Inc
MOGU Mogu Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from the AbbVie-owned distribution centers and public warehouses.

Price
Delayed
$155.42
Day's Change
1.20 (0.78%)
Bid
--
Ask
--
B/A Size
--
Day's High
156.03
Day's Low
154.46
Volume
(Light)

Today's volume of 1,197,679 shares is on pace to be much lighter than ABBV's 10-day average volume of 9,638,539 shares.

1,197,679
Historical quotes & splits

AbbVie to Present at the 41st Annual J.P. Morgan Healthcare Conference

8:00 am ET January 3, 2023 (PR Newswire) Print

AbbVie (NYSE: ABBV) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Richard A. Gonzalez, chairman and chief executive officer, will present at 5:00 p.m. CT.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTubeand LinkedIn.

https://mma.prnewswire.com/media/386913/AbbVie_logo.jpg

https://c212.net/c/img/favicon.png?sn=CG75261&sd=2023-01-03

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301711230.html

SOURCE AbbVie

https://rt.newswire.ca/rt.gif?NewsItemId=CG75261&Transmission_Id=202301030800PR_NEWS_USPR_____CG75261&DateId=20230103

comtex tracking

COMTEX_421819933/1005/2023-01-03T08:00:11

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure